Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women
By Rob Daniel
Jun 24, 2019 4:19 PM EDT
PRESS RELEASES
Palatin Technologies To Present At The H.C. Wainwright & Co. 22nd Annual Global Investment Conference
By PR Newswire
Sep 10, 2020 5:47 PM EDT
PRESS RELEASES
Palatin Technologies Participates In Canaccord Genuity's 40th Annual Growth Conference
By PR Newswire
Aug 13, 2020 4:12 PM EDT
PRESS RELEASES
Palatin Technologies, Inc. Announces Completion Of Enrollment Of Phase 2 Study With PL9643 For The Treatment Of Dry Eye Disease
By PR Newswire
Aug 5, 2020 7:30 AM EDT
PRESS RELEASES
Palatin Technologies Announces Mutual Termination Of License Agreement With AMAG Pharmaceuticals For Vyleesi®
By PR Newswire
Jul 27, 2020 7:00 AM EDT
PRESS RELEASES
Palatin Technologies, Inc. Announces Reinitiation Of Enrollment Of Phase 2 Study With PL9643 For The Treatment Of Dry Eye Disease
By PR Newswire
Jul 8, 2020 7:30 AM EDT
PRESS RELEASES
Palatin Technologies To Develop PL8177 As A Potential Treatment For COVID-19 And Associated Lung Complications
By PR Newswire
Jun 23, 2020 7:30 AM EDT
PRESS RELEASES
Palatin Technologies Provides Assessment Of Impact Of COVID-19 Pandemic On Business Operations
By PR Newswire
Apr 30, 2020 7:30 AM EDT
PRESS RELEASES
Palatin Technologies, Inc. Announces First Patient Enrolled In Dry Eye Disease Phase 2 Clinical Trial With PL9643
By PR Newswire
Feb 19, 2020 7:30 AM EST
PRESS RELEASES
Palatin Provides Corporate Update And 2020 Calendar Outlook
By PR Newswire
Jan 21, 2020 7:30 AM EST
STOCKS
Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women
By Rob Daniel
Jun 24, 2019 4:19 PM EDT
STOCKS
How to trade today's most active stocks: Ford, Palatin, more
By Jonas Elmerraji
Nov 2, 2016 12:44 PM EDT
STOCKS
Palatin female libido-boosting shot fails crucial sex frequency test
By Adam Feuerstein
Nov 2, 2016 7:20 AM EDT
MARKETS
Insider Trading Alert - AEL, PTN And BSX Traded By Insiders
By TheStreet Wire
Oct 6, 2015 10:45 AM EDT
MARKETS
Palatin Technologies (PTN) Stock Up After FDA Approval of 'Female Viagra'
By Tony Owusu
Aug 20, 2015 2:18 PM EDT
MARKETS
Palatin Technologies (PTN) Stock Climbing on FDA Approval of 'Female Viagra'
By Tony Owusu
Aug 19, 2015 2:20 PM EDT
MARKETS
Palatin Technologies (PTN) Strong On High Relative Volume Today
By TheStreet Wire
Jun 8, 2015 10:04 AM EDT
MARKETS
Palatin Technologies (PTN) Stock Spikes Following FDA Approval of 'Female Viagra' Treatment
By Tony Owusu
Jun 5, 2015 12:31 PM EDT
INVESTING
3 Stocks Under $10 to Trade for Breakouts
By Roberto Pedone
Apr 21, 2015 1:34 PM EDT
MARKETS
3 Stocks Pushing The Drugs Industry Lower
By TheStreet Wire
Aug 27, 2014 4:31 PM EDT
STOCKS
Biotech Stock Mailbag: Amarin, MannKind, Palatin
By Adam Feuerstein
May 24, 2013 7:00 AM EDT
INVESTING
5 Stocks Poised for Breakouts
By Roberto Pedone
Oct 26, 2012 1:24 PM EDT
STOCKS
Palatin Technologies' CEO Discusses F4Q12 Results - Earnings Call Transcript
By Seeking Alpha
Sep 11, 2012 2:50 PM EDT
STOCKS
Palatin Technologies' CEO Discusses F3Q2012 Results - Earnings Call Transcript
By Seeking Alpha
May 14, 2012 4:48 PM EDT
STOCKS
Palatin Technologies' CEO Discusses F2Q2012 Results - Earnings Call Transcript
By Seeking Alpha
Feb 15, 2012 2:15 PM EST